Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Huakang Biomedical Holdings Company Limited (HK:8622)
HKEX:8622
Holding HK:8622?
Track your performance easily
8622 Stock Chart & Stats
Day’s RangeHK$0 - HK$0
52-Week RangeHK$0.08 - HK$0.25
Previous CloseHK$0.18
Volume488.00K
Average Volume (3M)1.36M
Market Cap
HK$91.09M
Enterprise ValueN/A
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)―
Beta0.38
Next Earnings
Mar 20, 2025EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.01
Shares OutstandingN/A
10 Day Avg. Volume1,255,200
30 Day Avg. Volume1,360,262
Standard Deviation0.15
R-Squared0.00345
Alpha0.01
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)0.00
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
8622 FAQ
What was Huakang Biomedical Holdings Company Limited’s price range in the past 12 months?
Huakang Biomedical Holdings Company Limited lowest stock price was HK$0.08 and its highest was HK$0.25 in the past 12 months.
What is Huakang Biomedical Holdings Company Limited’s market cap?
Currently, no data Available
When is Huakang Biomedical Holdings Company Limited’s upcoming earnings report date?
Huakang Biomedical Holdings Company Limited’s upcoming earnings report date is Mar 20, 2025 which is in 87 days.
How were Huakang Biomedical Holdings Company Limited’s earnings last quarter?
Currently, no data Available
Is Huakang Biomedical Holdings Company Limited overvalued?
According to Wall Street analysts Huakang Biomedical Holdings Company Limited’s price is currently Overvalued.
Does Huakang Biomedical Holdings Company Limited pay dividends?
Huakang Biomedical Holdings Company Limited does not currently pay dividends.
What is Huakang Biomedical Holdings Company Limited’s EPS estimate?
Huakang Biomedical Holdings Company Limited’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Huakang Biomedical Holdings Company Limited have?
Huakang Biomedical Holdings Company Limited has 500,472,000 shares outstanding.
What happened to Huakang Biomedical Holdings Company Limited’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Huakang Biomedical Holdings Company Limited?
Currently, no hedge funds are holding shares in HK:8622
---
Huakang Biomedical Holdings Company Limited Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Positive
20 days / 200 days
Momentum
87.62%
12-Months-Change
Fundamentals
Return on Equity
-11.03%
Trailing 12-Months
Asset Growth
3.73%
Trailing 12-Months
Company Description
Huakang Biomedical Holdings Company Limited
Huakang Biomedical Holdings Co Ltd is engaged in the research, development, manufacture, marketing and sale of in-vitro diagnostic reagents and auxiliary reproductive supplies and equipment in China. Its products include Male fertility IVD reagents; Parasite antibody detection reagents; EBV antibody detection reagent; and Auxiliary reproductive supplies and equipment. The group has also diversified its business to vitamins and supplements products for the markets in the PRC, Hong Kong and overseas.
---
Technical Analysis
Kinetix Systems Holdings Limited
―
China TianYF Holdings Group Limited
―
Good Fellow Healthcare Holdings Limited
―
Hong Wei (Asia) Holdings Co Ltd
―
---